"analogous stem cell transplant; PET; Hodgkin lymphoma"@en . . . . "Trn\u011Bn\u00FD, Marek" . "The retrospective study evaluated the secondary clinical risk score at relapse, the prognostic significance of pre-transplant positron emission tomography (PET), and complete remission (CR) assessed by computed tomography (CT) after salvage chemotherapy before autologous stem cell transplant (ASCT) in 76 patients with relapsed/refractory Hodgkin lymphoma (HL). Median follow-up after ASCT was 23 months. Overall 11/20 PET-positive and 14/56 PET-negative patients relapsed after ASCT. In univariate analysis, only PET negativity before ASCT was significantly associated with better 2-year progression-free survival (PFS) and 2-year overall survival (OS). Other factors were not significant. In multivariate analysis, none of the evaluated factors were significant for PFS and OS. However, positive pre-transplant PET identified a population with worse PFS and OS at least in univariate analysis."@en . . . "Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma"@en . . . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "000294228100010" . "RIV/00669806:_____/11:10107683!RIV12-MZ0-00669806" . . . . "Pytl\u00EDk, Robert" . "9" . "12"^^ . "Mayer, Ji\u0159\u00ED" . "Markov\u00E1, Jana" . . "The retrospective study evaluated the secondary clinical risk score at relapse, the prognostic significance of pre-transplant positron emission tomography (PET), and complete remission (CR) assessed by computed tomography (CT) after salvage chemotherapy before autologous stem cell transplant (ASCT) in 76 patients with relapsed/refractory Hodgkin lymphoma (HL). Median follow-up after ASCT was 23 months. Overall 11/20 PET-positive and 14/56 PET-negative patients relapsed after ASCT. In univariate analysis, only PET negativity before ASCT was significantly associated with better 2-year progression-free survival (PFS) and 2-year overall survival (OS). Other factors were not significant. In multivariate analysis, none of the evaluated factors were significant for PFS and OS. However, positive pre-transplant PET identified a population with worse PFS and OS at least in univariate analysis." . "Koza, Vladim\u00EDr" . "Koz\u00E1k, Tom\u00E1\u0161" . "Leukemia and Lymphoma" . "1042-8194" . . "Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma" . "Belada, David" . . "1"^^ . "Steinerov\u00E1, Kate\u0159ina" . "10.3109/10428194.2011.573889" . . "[BDABF57FCD69]" . "RIV/00669806:_____/11:10107683" . . "Trnkov\u00E1, Marie" . "Mocikov\u00E1, Heidi" . "223186" . "Kr\u00E1l, Zden\u011Bk" . "Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma"@en . . . . "\u017D\u00E1k, Pavel" . "Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma" . "http://www.ncbi.nlm.nih.gov/pubmed/21699377" . "52" . "7"^^ . "I, N, S, V, Z(MSM0021620808)" . .